Potent, cell permeable cysteine thioether displaying anti-mitotic and anti-tumor properties. Inhibits mitosis by blocking basal and microtubule-activated ATPase activities of the mitotic kinesin Eg5 (IC50=1µM and 140nm). Induces mitotic arrest in HeLa cells (IC50=700nM) and inhibits the growth of NCI tumor cell line panel (GI50=1.31µM).
Product Details
Alternative Name: | NSC 83265, STLC |
|
Formula: | C22H21NO2S |
|
MW: | 363.5 |
|
CAS: | 2799-07-7 |
|
RTECS: | AY7710000 |
|
Purity: | ≥98% (TLC) |
|
Appearance: | White to off-white solid. |
|
Solubility: | Soluble in DMSO or acetic acid. |
|
Shipping: | Ambient |
|
Long Term Storage: | -20°C |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
A mitotic chromatin phase transition prevents perforation by microtubules: M.W.G. Schneider, et al.; Nature
609, 183 (2022),
Abstract;
A PKD-MFF signaling axis couples mitochondrial fission to mitotic progression: E. Pangou, et al.; Cell Rep.
35, 109129 (2021),
Abstract;
S-trityl-l-cysteine is a reversible, tight-binding inhibitor of the human kinesin eg5 that specifically blocks mitotic progression: D.A. Skoufias, et al.; J. Biol. Chem.
281, 17559 (2006),
Abstract;
Full Text
In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities: S. DeBonis, et al.; Mol. Cancer Ther.
3, 1079 (2004),
Abstract;
Full Text